Dupont Capital Management’s Innoviva INVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-16,780
Closed -$325K 1697
2022
Q1
$325K Sell
16,780
-1,485
-8% -$26.5K 0.01% 903
2021
Q4
$315K Sell
18,265
-24,484
-57% -$417K 0.01% 959
2021
Q3
$714K Sell
42,749
-6,042
-12% -$90.4K 0.02% 715
2021
Q2
$654K Sell
48,791
-8,900
-15% -$111K 0.02% 839
2021
Q1
$689K Sell
57,691
-11,832
-17% -$143K 0.02% 776
2020
Q4
$861K Sell
69,523
-5,189
-7% -$56K 0.02% 617
2020
Q3
$781K Sell
74,712
-5,004
-6% -$63.6K 0.02% 587
2020
Q2
$1.11M Sell
79,716
-7,117
-8% -$96.8K 0.02% 475
2020
Q1
$1.02M Sell
86,833
-16,694
-16% -$221K 0.02% 444
2019
Q4
$1.47M Hold
103,527
0.03% 443
2019
Q3
$1.09M Sell
103,527
-11,099
-10% -$133K 0.03% 494
2019
Q2
$1.67M Hold
114,626
0.04% 407
2019
Q1
$1.61M Hold
114,626
0.04% 417
2018
Q4
$2M Hold
114,626
0.05% 354
2018
Q3
$1.75M Hold
114,626
0.04% 427
2018
Q2
$1.58M Buy
+114,626
New +$1.72M 0.04% 438
2018
Q1
Sell
-43,339
Closed -$615K 981
2017
Q4
$615K Sell
43,339
-38,208
-47% -$510K 0.01% 610
2017
Q3
$1.15M Hold
81,547
0.03% 491
2017
Q2
$1.04M Buy
+81,547
New +$1.02M 0.02% 520

Other funds holding INVA

Dupont Capital Management's INVA Position: Q2 2022 in Review

Dupont Capital Management sold out of Innoviva (INVA) in Q2 2022, closing a stake of 16,780 shares — an estimated $325K sold.

Dupont Capital Management first reported a position in INVA in Q2 2017 and held it in 19 quarters. The position peaked at $2M in Q4 2018. 218 funds tracked by Wall St. Rank hold INVA as of Q2 2022.

  • Dupont Capital Management reported no remaining Innoviva position as of Q2 2022 after selling out during the quarter.
  • Dupont Capital Management sold 16,780 Innoviva shares in Q2 2022, an estimated $325K.
  • Dupont Capital Management first reported a position in Innoviva in Q2 2017 and held it in 19 quarters.
  • Dupont Capital Management's Innoviva position peaked at $2M in Q4 2018.
  • 218 funds tracked by Wall St. Rank held Innoviva as of Q2 2022.

Based on Dupont Capital Management's 13F filing for Q2 2022, filed 26 Jul 2022.